Using simulated maps to interpret the geochemistry and formation of the Blue Gem Coal Bed, Kentucky, USA

This study presents geostatistical simulations of coal-quality parameters, major oxides and trace metals for an area covering roughly 812 km2 of the Blue Gem coal bed in southeastern Kentucky, USA. The Blue Gem, characterized by low ash yield and low sulfur content, is an important economic resource. Past studies have characterized the Blue Gem\u27s geochemistry, palynology and petrography and inferred a depositional setting of a planar peat deposit that transitioned to slightly domed later in its development. These studies have focused primarily on vertical geochemical trends within the coal bed. Simulated maps of chemical elements derived from 45 measured sample locations across the study area provide an opportunity to observe changes in the horizontal direction within the coal bed. As the Blue Gem coal bed shows significant vertical chemical trends, care was taken in this study to try to select samples from a single, middle portion of the coal. By revealing spatial distribution patterns of elements across the middle of the bed, associations between different components of the coal can be seen. The maps therefore help to provide a picture of the coal-forming peat bog at an instant in geologic time and allow the interpretation of a depositional setting in the horizontal direction. Results from this middle portion of the coal suggest an association of SiO2 with both K2O and TiO2 in different parts of the study area. Further, a pocket in the southeast of the study area shows elevated concentrations of elements attributable to observed carbonate-phase minerals (MgO, CaO, Ba and Sr) as well as elements commonly associated with sulfide-phase minerals (Cu, Mo and Ni). Areas of relatively high ash yield are observed in the north and south of the mapped area, in contrast to the low ash yields seen towards the east. Additionally, we present joint probability maps where multiple coal-quality parameters are plotted simultaneously on one figure. This application allows researchers to investigate the associations of more than two components in a straight-forward manner useful in guiding resource exploration

Direct estimation of diffuse gaseous emissions from coal fires: Current methods and future directions

Coal fires occur in nature spontaneously, contribute to increases in greenhouse gases, and emit atmospheric toxicants. Increasing interest in quantifying coal fire emissions has resulted in the adaptation and development of specialized approaches and adoption of numerical modeling techniques. Overview of these methods for direct estimation of diffuse gas emissions from coal fires is presented in this paper. Here we take advantage of stochastic Gaussian simulation to interpolate CO2 fluxes measured using a dynamic closed chamber at the Ruth Mullins coal fire in Perry County, Kentucky. This approach allows for preparing a map of diffuse gas emissions, one of the two primary ways that gases emanate from coal fires, and establishing the reliability of the study both locally and for the entire fire. Future research directions include continuous and automated sampling to improve quantification of gaseous coal fire emissions

Modeling Leakage Kinetics from Multilamellar Vesicles for Membrane Permeability Determination: Application to Glucose

The glucose permeability of bilayers formed from phosphatidylcholine, Brij30, and sodium octadecyl sulfate has been determined via an enzymatic reaction. Glucose is encapsulated in either uni- or multilamellar vesicles (MLV) and its concentration in the dispersion medium is monitored by spectrophotometry analysis through the rate of glucose oxidase-catalyzed reaction of glucose oxidation. A kinetic model of leakage, taking explicitly into account one, two, or n(w)-walls (n(w) » 1) for the vesicles and assuming an enzymatic Michaelis-Menten behavior, is proposed and used to fit the experimental data. The two-wall model was chosen to fit experimental data obtained on MLV since an average value of 1.7 bilayers was estimated for MLV by cryo-TEM imaging. A permeability value of 5.8 ± 4.4 10(−9) cm/s was found. The proposed model is validated by the measurement of the bilayer permeability deduced from the modeling of glucose leakage from unilamellar vesicles with the same composition. In this latter case, a value of 8.3 ± 0.7 10(−9) cm/s is found for the permeability, which is within the error bar of the value found with MLV

A CASCADE of effects of bisphenol A

International audienc

Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research

A study published in Toxicological Sciences (Ryan et al., 2009) illustrates the importance of examining appropriate doses of both the positive control and the test chemical in research on endocrine-disrupting chemicals. For the three low doses of bisphenol A (BPA) that were fed to rats during pregnancy and lactation, there were no effects on female offspring (there were also no effects on male offspring from the same experiment; Howdeshell et al., 2008). A review of the results of the positive control doses makes it clear that the experiment cannot adequately assess the consequences of low-dose exposure to BPA because the animal model is insensitive to low doses of the positive control estrogen. Therefore, conclusions being drawn from this experiment about low-dose responses to any estrogen are invalid, including that of “no harm” from the low doses of BPA that were tested. However, the experiment is important because it highlights the need to apply basic principles of study design, long known and accepted in studies of hormones and hormonally active drugs, to toxicological studies of chemicals with hormonal activity

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.

BACKGROUND: Central nervous system Langerhans cell histiocytosis (CNS-LCH) brain involvement may include mass lesions and/or a neurodegenerative disease (LCH-ND) of unknown etiology. The goal of this study was to define the mechanisms of pathogenesis that drive CNS-LCH. METHODS: Cerebrospinal fluid (CSF) biomarkers including CSF proteins and extracellular BRAFV600E DNA were analyzed in CSF from patients with CNS-LCH lesions compared with patients with brain tumors and other neurodegenerative conditions. Additionally, the presence of BRAFV600E was tested in peripheral mononuclear blood cells (PBMCs) as well as brain biopsies from LCH-ND patients, and the response to BRAF-V600E inhibitor was evaluated in 4 patients with progressive disease. RESULTS: Osteopontin was the only consistently elevated CSF protein in patients with CNS-LCH compared with patients with other brain pathologies. BRAFV600E DNA was detected in CSF of only 2/20 (10%) cases, both with LCH-ND and active lesions outside the CNS. However, BRAFV600E+ PBMCs were detected with significantly higher frequency at all stages of therapy in LCH patients who developed LCH-ND. Brain biopsies of patients with LCH-ND demonstrated diffuse perivascular infiltration by BRAFV600E+ cells with monocyte phenotype (CD14+ CD33+ CD163+ P2RY12- ) and associated osteopontin expression. Three of 4 patients with LCH-ND treated with BRAF-V600E inhibitor experienced significant clinical and radiologic improvement. CONCLUSION: In LCH-ND patients, BRAFV600E+ cells in PBMCs and infiltrating myeloid/monocytic cells in the brain is consistent with LCH-ND as an active demyelinating process arising from a mutated hematopoietic precursor from which LCH lesion CD207+ cells are also derived. Therapy directed against myeloid precursors with activated MAPK signaling may be effective for LCH-ND. Cancer 2018;124:2607-20. © 2018 American Cancer Society

CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions

BACKGROUND: Central nervous system Langerhans cell histiocytosis (CNS-LCH) brain involvement may include mass lesions and/or a neurodegenerative disease (LCH-ND) of unknown etiology. The goal of this study was to define the mechanisms of pathogenesis that drive CNS-LCH. METHODS: Cerebrospinal fluid (CSF) biomarkers including CSF proteins and extracellular BRAFV600E DNA were analyzed in CSF from patients with CNS-LCH lesions compared with patients with brain tumors and other neurodegenerative conditions. Additionally, the presence of BRAFV600E was tested in peripheral mononuclear blood cells (PBMCs) as well as brain biopsies from LCH-ND patients, and the response to BRAF-V600E inhibitor was evaluated in 4 patients with progressive disease. RESULTS: Osteopontin was the only consistently elevated CSF protein in patients with CNS-LCH compared with patients with other brain pathologies. BRAFV600E DNA was detected in CSF of only 2/20 (10%) cases, both with LCH-ND and active lesions outside the CNS. However, BRAFV600E+ PBMCs were detected with significantly higher frequency at all stages of therapy in LCH patients who developed LCH-ND. Brain biopsies of patients with LCH-ND demonstrated diffuse perivascular infiltration by BRAFV600E+ cells with monocyte phenotype (CD14+ CD33+ CD163+ P2RY12- ) and associated osteopontin expression. Three of 4 patients with LCH-ND treated with BRAF-V600E inhibitor experienced significant clinical and radiologic improvement. CONCLUSION: In LCH-ND patients, BRAFV600E+ cells in PBMCs and infiltrating myeloid/monocytic cells in the brain is consistent with LCH-ND as an active demyelinating process arising from a mutated hematopoietic precursor from which LCH lesion CD207+ cells are also derived. Therapy directed against myeloid precursors with activated MAPK signaling may be effective for LCH-ND. Cancer 2018;124:2607-20. © 2018 American Cancer Society